1.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

2.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

3.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

4.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

5.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

6.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

7.

The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.

1.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

2.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

3.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

4.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

5.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

6.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

7.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

8.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

9.

Determinants of the geographic distribution of Puumala virus and Lyme borreliosis infections in Belgium.

1.

Lyme disease in the Dutch policy context: patient consultation in government research agenda setting

2.

Lyme disease in the Dutch policy context: patient consultation in government research agenda setting

3.

Lyme disease in the Dutch policy context: patient consultation in government research agenda setting

4.

Lyme disease in the Dutch policy context: patient consultation in government research agenda setting

5.

Lyme disease in the Dutch policy context: patient consultation in government research agenda setting

6.

Lyme disease in the Dutch policy context: patient consultation in government research agenda setting

7.

Lyme disease in the Dutch policy context: patient consultation in government research agenda setting

1.

Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis : a prospective cohort study in Belgium (2016–2020)

1.

Spatial and temporal variation in tick abundance and infection in six residential neighborhoods in Dutchess County, NY

1.

Risk of infections transmitted by arthropods and rodents in forestry workers.